Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrolide vs Glucocorticoid in Post-ESS Chronic Rhinosinusitis
NCT02182492Completed
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of clarithromycin in chronic rhinosinusitis (CRS) (2 arms). Primary endpoint: Total Subjective Symptoms Visual Analog Scores at 12 months. Started Jan 2014; status: completed.
02
Drugs
clarithromycin
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT02182492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182492.